Insider Transactions in Q4 2021 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2021
|
Richard A Barasch Director |
BUY
Open market or private purchase
|
Direct |
5,000
+1.73%
|
$30,000
$6.96 P/Share
|
|
Nov 23
2021
|
Richard A Barasch Director |
BUY
Open market or private purchase
|
Direct |
5,000
+2.64%
|
$30,000
$6.31 P/Share
|
|
Nov 16
2021
|
Richard A Barasch Director |
BUY
Open market or private purchase
|
Direct |
1,000
+1.15%
|
$10,000
$10.12 P/Share
|
|
Nov 12
2021
|
Dfp Sponsor LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
40
+50.0%
|
-
|
|
Nov 12
2021
|
Mohit Kaushal Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,466
-14.89%
|
-
|
|
Nov 12
2021
|
Mohit Kaushal Director |
BUY
Conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
Nov 12
2021
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
195,236
+43.75%
|
-
|
|
Nov 12
2021
|
Ravi Yang Sarin Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,109,771
+50.0%
|
-
|
|
Nov 12
2021
|
Scott Dalgleish Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,916
+43.75%
|
-
|
|
Nov 12
2021
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,398
+50.0%
|
-
|
|
Nov 12
2021
|
Richard A Barasch Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,887
-14.89%
|
-
|
|
Nov 12
2021
|
Richard A Barasch Director |
BUY
Conversion of derivative security
|
Direct |
100,000
+50.0%
|
-
|
|
Nov 12
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
85,153
+50.0%
|
-
|